Head to head
Cleveland-Cliffs vs Nucor
Side-by-side on the measures that matter, with a plain-English read. Full detail: CLF · NUE
CLF
Cleveland-Cliffs
10.67-8.96%
1-year price shape — -3% over the period
Quant Rating D · 34/100
vs
NUE
Nucor
239.62-3.16%
1-year price shape — +64% over the period
Quant Rating C · 91/100
1-year performance, rebased to 100
Nucor edges it on the scoreable measures. Nucor has the highest Quant Rating (91); Nucor has done best over the past year (+64%); Nucor pays the highest dividend yield.
| CLF | NUE | |
|---|---|---|
| Snapshot | ||
| Sector | -- | Steel |
| Last price | 10.67 | 239.62 |
| Change today | -8.96% | -3.16% |
| 1-year return | -2.8% | +64.3% |
| Market cap | $6.09B | $53.90B |
| 52-week range | 7.73 – 15.35 | 149.11 – 287.70 |
| Valuation | ||
| P/E (TTM) | -13.01 | 15.26 |
| P/E percentile, own 5-yr range | 1st | 68th |
| P/B | 1.07 | 2.36 |
| Dividend yield | 0.00% | 0.93% |
| Profitability & growth | ||
| EPS (TTM) | -2.91 | 7.52 |
| Net profit (TTM) | $-1.66B | $1.69B |
| Revenue (TTM) | $20.07B | $38.83B |
| Provider revenue period date | 2026-09-29 | 2026-10-02 |
| Revenue growth (YoY) | +18.5% | +32.0% |
| Gross margin | 1.5% | 17.3% |
| Operating margin | -1.4% | 13.3% |
| Net margin | -2.4% | 9.2% |
| Free cash flow (TTM) | $-485.00M | $2.66B |
| Provider cash-flow period date | 2026-09-29 | 2026-10-02 |
| Ownership & sentiment | ||
| Institutional ownership | 85.3% | 80.7% |
| Insider activity (12mo) | 34 buy / 15 sell | 25 buy / 25 sell |
| Short interest (% of float) | 10.8% | 1.9% |
| Analyst consensus | 38% buy / 62% hold (8) | 100% buy (10) |
| Analyst price target | $15 (+36%) | $308 (+28%) |
| StockVane view | ||
| StockVane Quant Rating | D (34) | C (91) |
| Company | ||
| Employees | 25,000 | 33,000 |
| Founded | 1847 | 1958 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.